Ashley Hall, Chief Development Officer at Reneo Pharmaceuticals, Inc. (RPHM), sold 15,625 shares at $6.28 ($98K) on 2023-08-28, disclosed to the SEC on 2023-08-29.
Open-market sale of $98k RPHM by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.